Triple antiviral therapy in HCV positive patients who failed prior combination therapy

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 12, Issue 33

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

362

HTML

2467

Figures (1-2)

269

Tables (1-4)

259

Sum=3357

Sep 7, 2006 (publication date) through Feb 21, 2025

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Viral Hepatitis

World J Gastroenterol. Sep 7, 2006; 12(33): 5293-5300
Published online Sep 7, 2006. doi: 10.3748/wjg.v12.i33.5293

Table 4 Reasons for treatment discontinuation

	PegIFN +RBV+ AMA(n = 106)	IFN+RBV+AMA(n = 82)
Treatment discontinuation for any	10 (9.4%)	17 (20.7%)
Reason¹
Study drug noncompliance	2	11
Demyelinizing neuropathy	1
Depression	1	1
Erythema		1
Pulmonary fibrosis	1
Hyperthyroidism	1
Hyperthyroidism & Insomnia	1
Increased ALT		1
Leukopenia	1	3
Dyspnoea, Cough, Pruritus	1
Unknown reason	1

¹ Fisher’s exact test: P = 0.036.

Citation: Fargion S, Borzio M, Maraschi A, Cargnel A, Lombardo TPOTGE. Triple antiviral therapy in HCV positive patients who failed prior combination therapy. World J Gastroenterol 2006; 12(33): 5293-5300
URL: https://www.wjgnet.com/1007-9327/full/v12/i33/5293.htm
DOI: https://dx.doi.org/10.3748/wjg.v12.i33.5293